Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar 5;3(3):e0370.
doi: 10.1097/CCE.0000000000000370. eCollection 2021 Mar.

Standard Sedation and Sedation With Isoflurane in Mechanically Ventilated Patients With Coronavirus Disease 2019

Affiliations

Standard Sedation and Sedation With Isoflurane in Mechanically Ventilated Patients With Coronavirus Disease 2019

Dusan Hanidziar et al. Crit Care Explor. .

Abstract

Objectives: To describe sedative and analgesic drug utilization in a cohort of critically ill patients with coronavirus disease 2019 and compare standard sedation with an alternative approach using inhaled isoflurane.

Design: This was a retrospective cohort study designed to compare doses of sedatives between ICU patients receiving standard IV sedation and patients receiving mixed sedation including inhaled isoflurane. Data were obtained from electronic medical records.

Setting: ICU at large academic medical center where mechanical ventilation was delivered with Draeger Apollo (Draeger Medical, Telford, PA) anesthesia machines.

Patients: Consecutive adult patients (≥ 18 yr) with confirmed coronavirus disease 2019 admitted to ICU between April 2, 2020, and May 4, 2020.

Interventions: None.

Measurements and main results: Thirty-five mechanically ventilated patients were included in the study, with a mean (sd) age of 59.4 (12.8) years. Twenty-three patients (65.7%) were men. Seventeen patients (48.6%) received standard IV sedation, whereas 18 (51.4%) also received isoflurane. The mean duration of mechanical ventilation (sd) was 23.3 (11.6) days in the standard sedation group and 23.8 (12.5) days in the isoflurane group. Mean (sd) duration of isoflurane exposure was 5.61 (2.99) days, representing 29.1% of total sedation time (sd, 20.4). Cumulative opioid exposure did not differ between the standard sedation and isoflurane sedation groups (mean morphine milligram equivalent 6668 [sd, 1,346] vs 6678 [sd, 2,000] mg). However, the initiation of isoflurane in patients was associated with decreased utilization of propofol (mean daily amount 3,656 [sd, 1,635] before vs 950 [sd, 1,804] mg during isoflurane) and hydromorphone (mean daily amount 48 [sd, 30] before vs 23 [sd, 27] mg).

Conclusions: In the subjects that received isoflurane, its use was associated with significant decreases in propofol and hydromorphone infusions.

Keywords: acute respiratory distress syndrome; coronavirus disease 2019; isoflurane; sedation.

PubMed Disclaimer

Conflict of interest statement

Dr. Hanidziar is supported by Clinical Investigator Award from National Heart, Lung and Blood Institute (K08HL141694). Dr. Xie is supported by grant from National Institute on Aging (R01AG062509). The remaining authors have disclosed that they do not have any potential conflicts of interest.

References

    1. Ziehr DR, Alladina J, Petri CR, et al. . Respiratory pathophysiology of mechanically ventilated patients with COVID-19: A cohort study. Am J Respir Crit Care Med. 2020; 201:1560–1564 - PMC - PubMed
    1. Hanidziar D, Bittner EA. Sedation of mechanically ventilated COVID-19 patients: Challenges and special considerations. Anesth Analg. 2020; 131:e40–e41 - PMC - PubMed
    1. Kapp CM, Zaeh S, Niedermeyer S, et al. . The use of analgesia and sedation in mechanically ventilated patients with COVID-19 acute respiratory distress syndrome. Anesth Analg. 2020; 131:e198–e200 - PMC - PubMed
    1. Jerath A, Ferguson ND, Cuthbertson B. Inhalational volatile-based sedation for COVID-19 pneumonia and ARDS. Intensive Care Med. 2020; 46:1563–1566 - PMC - PubMed
    1. Flinspach AN, Zacharowski K, Ioanna D, et al. . Volatile isoflurane in critically ill coronavirus disease 2019 patients-A case series and systematic review. Crit Care Explor. 2020; 2:e0256. - PMC - PubMed